Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.01
67.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co Ltd
Total Equity
Guangzhou Kingmed Diagnostics Group Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Equity
¥7.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Total Equity
¥2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Total Equity
¥3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Equity
¥17.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Equity
¥7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
28%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Equity
¥7.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
36%
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
Glance View
Guangzhou Kingmed Diagnostics Group Co., Ltd. engages in the provision of outsourced medical examination and pathological diagnosis services to medical institutions. The company is headquartered in Guangzhou, Guangdong and currently employs 12,371 full-time employees. The company went IPO on 2017-09-08. The firm is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
See Also
What is Guangzhou Kingmed Diagnostics Group Co Ltd's Total Equity?
Total Equity
7.8B
CNY
Based on the financial report for Sep 30, 2024, Guangzhou Kingmed Diagnostics Group Co Ltd's Total Equity amounts to 7.8B CNY.
What is Guangzhou Kingmed Diagnostics Group Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
29%
Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for Guangzhou Kingmed Diagnostics Group Co Ltd have been 12% over the past three years , 29% over the past five years .
You don't have any saved screeners yet
